10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q1 2018

Filing Information

Form Type	10-Q
Accession Number	`0001213900-17-012121`
Period End Date	20170930
Filing Date	20171114
Fiscal Year	2018
Fiscal Period	Q1
XBRL Instance	rlmd-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 22 Cash Flow Statement 60

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Promissory notes payable, net of discount	`DebtInstrumentUnamortizedDiscountNoncurrent`	$3.80M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.68M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.22M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$232.60K	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$150.62K	USD	Point-in-time
Lease payments receivable - short term	`LeaseIncentiveReceivableCurrent`	$59.32K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Lease payments receivable - short term	`LeaseIncentiveReceivableCurrent`	$60.57K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$369.38K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$472.49K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.47M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.27M	USD	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$2.31K	USD	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$4.36K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.55M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.53M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.53M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.55M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$21.96K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$21.96K	USD	Point-in-time
Lease payments receivable - long term	`LeaseIncentiveReceivableNoncurrent`	$337.73K	USD	Point-in-time
Lease payments receivable - long term	`LeaseIncentiveReceivableNoncurrent`	$322.11K	USD	Point-in-time
Total assets	`Assets`	$2.84M	USD	Point-in-time
Total assets	`Assets`	$5.61M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$529.56K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$350.54K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$394.56K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$407.31K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$194.16K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$276.67K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$2.52M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$175.85K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.38M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.47M	USD	Point-in-time
Promissory notes payable, net of discount of $3,801,125	`LongTermNotesPayable`	-	USD	Point-in-time
Promissory notes payable, net of discount of $3,801,125	`LongTermNotesPayable`	$678.88K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.38M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.15M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value,100,000,000 shares authorized, 12,545,120 and 12,528,374 shares issued and outstanding, respectively	`CommonStockValue`	$12.53K	USD	Point-in-time
Common stock, $0.001 par value,100,000,000 shares authorized, 12,545,120 and 12,528,374 shares issued and outstanding, respectively	`CommonStockValue`	$12.54K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$86.83M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$87.82M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-85.38M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-86.37M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$1.46M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$1.46M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.61M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$2.84M	USD	Point-in-time

Income Statement 22 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$165.75K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$364.15K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.25M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$815.11K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$1.62M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$980.86K	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-980.86K	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-1.62M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-80.04K	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-5.70K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$-851.00	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$2.52K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$2.35K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$56.91K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-23.98K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-830.00	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-981.69K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.64M	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.14	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	1 Quarter
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.04M	shares	1 Quarter
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.53M	shares	1 Quarter

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-981.69K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.64M	USD	1 Quarter
Depreciation expense	`Depreciation`	$20.16K	USD	1 Quarter
Depreciation expense	`Depreciation`	$548.00	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$172.06K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$68.87K	USD	1 Quarter
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	$2.82K	USD	1 Quarter
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$5.70K	USD	1 Quarter
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$80.04K	USD	1 Quarter
Other receivable	`IncreaseDecreaseInOtherReceivables`	$-81.98K	USD	1 Quarter
Other receivable	`IncreaseDecreaseInOtherReceivables`	$2.35K	USD	1 Quarter
Lease payment receivable	`IncreaseDecreaseInLeasePaymentReceivable`	-	USD	1 Quarter
Lease payment receivable	`IncreaseDecreaseInLeasePaymentReceivable`	$-14.37K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$-50.31K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$-103.11K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-587.99K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-232.51K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-229.97K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-42.25K	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-6.18K	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.14M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-979.05K	USD	1 Quarter
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$2.59K	USD	1 Quarter
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$24.83K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-2.59K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-24.83K	USD	1 Quarter
Proceeds from promissory notes and warrants, net of fees	`ProceedsFromNotesPayable`	$4.04M	USD	1 Quarter
Proceeds from promissory notes and warrants, net of fees	`ProceedsFromNotesPayable`	-	USD	1 Quarter
Principal payments of note payable	`RepaymentsOfNotesPayable`	$82.51K	USD	1 Quarter
Principal payments of note payable	`RepaymentsOfNotesPayable`	$109.23K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$3.96M	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-109.23K	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.28M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.97M	USD	1 Quarter
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.68M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$6.22M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.68M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$6.22M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	-	USD	1 Quarter
Income taxes	`IncomeTaxesPaidNet`	-	USD	1 Quarter
Interest	`InterestPaid`	$2.64K	USD	1 Quarter
Interest	`InterestPaid`	$1.97K	USD	1 Quarter
Issuances of common stock resulting from cashless exercise of warrants	`StockIssued1`	-	USD	1 Quarter
Issuances of common stock resulting from cashless exercise of warrants	`StockIssued1`	$17.00	USD	1 Quarter
Warrants issued to placement agent	`WarrantsIssuedToPlacementAgent`	-	USD	1 Quarter
Warrants issued to placement agent	`WarrantsIssuedToPlacementAgent`	$75.58K	USD	1 Quarter
Warrants issued to promissory note holders	`WarrantsIssuedToPromissoryNoteHolders`	$841.62K	USD	1 Quarter
Warrants issued to promissory note holders	`WarrantsIssuedToPromissoryNoteHolders`	-	USD	1 Quarter
Derivative associated with issuance of promissory notes	`DerivativeAssociatedWithIssuanceOfPromissoryNotes`	-	USD	1 Quarter
Derivative associated with issuance of promissory notes	`DerivativeAssociatedWithIssuanceOfPromissoryNotes`	$2.34M	USD	1 Quarter
Debt issuance cost from accrued financing fees	`AccruedFinancingFees`	$108.49K	USD	1 Quarter
Debt issuance cost from accrued financing fees	`AccruedFinancingFees`	-	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.